To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...
Dual-Agonist Anti-Inflammatory Compounds
New approach to promote resolution of inflammation. Developed hybrid compounds that are dual agonists of FPR2 and GPR32.
Lead: Dr. Eoin Brennan, Prof. Catherine Godson, Prof. Patrick Guiry
